BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 1 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -57.1% | 12,700 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -97.5% | 12,700 | -90.8% | 0.00% | -100.0% |
| Q1 2022 | $282,000 | +4.4% | 137,700 | +818.0% | 0.01% | 0.0% |
| Q2 2021 | $270,000 | +315.4% | 15,000 | -14.3% | 0.01% | +400.0% |
| Q1 2021 | $65,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |